Method and apparatus for treating refractive eye abnormalities

• US 5,838,419 A
• Filed: 02/22/1996
• Issued: 11/17/1998
• Est. Priority Date: 02/22/1996
• Status: Expired due to Term

• Current Assignee: Stephen Holland
• Original Assignee: Stephen Holland
• Inventors: Holland, Stephen
• Primary Examiner(s): Sugarman, Scott J.
• Application Number:
  US08/605,377
• Time in Patent Office: 999 Days
• Field of Search: 351/160 R, 351/160 H, 351/161, 351/162, 351/177, 351/163, 351/165, 351/176, 623/6
• US Class Current: 351/177
• CPC Class Codes: A61F 2/1613 having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
• CPC Class Codes: G02C 2202/24 Myopia progression prevention
• CPC Class Codes: G02C 7/02 Lenses; Lens systems ; Methods of designing lenses
• CPC Class Codes: G02C 7/04 Contact lenses for the eyes disinfection or sterilisation of contact lenses A61L12/00
• CPC Class Codes: G02C 7/104 having spectral characteristics for purposes other than sun-protection

Abstract

A method for treating refractive eye abnormalities, including myopia, hyperopia, and astigmatism, by shifting the spectral distribution of incident light is described. Optical filters or tints are provided on eyeglasses, contact lenses, intra-ocular implants, or at ambient light sources to shift the spectral distribution of light entering the eye being treated. Ambient light sources emitting at specified spectral distribution or wavelength range can also be used. In this way, the average spectral distribution of visible light incident to an eye is controlled to treat refractive eye abnormalities. Changes in the eyeball shape and focus resulting from an eye'"'"'s response to the spectral distribution of light are prevented, mitigated, halted, or even reversed. The visible spectral content is shifted to shorter or longer wavelengths over an entire field of view detected by the retina to treat myopia and hyperopia respectively. To correct for astigmatism, the spectral distribution of light is shifted within selected areas of a retina field of view corresponding to an abnormal power.

Claims

1. A method for treating a refractive abnormality, comprising the steps of:

identifying a refractive abnormality of an eye; and

treating said refractive abnormality by controlling a spectral power distribution of visible light incident to the eye to effect a change in the shape of the eve over time.

2. The method of claim 1, wherein said refractive abnormality comprises at least one refractive abnormality selected from the group of myopia, hyperopia, and astigmatism.

3. The method of claim 1, wherein said spectral power distribution controlling step comprises the step of filtering incident light to the eye.

4. The method of claim 3, wherein said filtering step comprises the step of providing at least one blue light filter in a field of view of the eye to treat myopia.

5. The method of claim 4, wherein said providing step comprises the step of converting the spectral power distribution of ambient artificial light to approximate the spectral distribution of sunlight.

6. The method of claim 4, wherein said at least one blue light filter has a Mired shift value approximately equal to -160;

and said providing step comprises the step of converting the spectral power distribution of ambient light using said at least one blue light filter having a Mired shift value approximately equal to -160.

7. The method of claim 6, wherein said at least one blue light filter comprises two Wratten 80C filters;

and said providing step comprises the step of converting the spectral power distribution of ambient light using the two Wratten 80C filters.

8. The method of claim 3, wherein said filtering step comprises the step of providing at least one red filter to treat hyperopia.

9. The method of claim 3, wherein said filtering step comprises the step of providing a sectioned-filter having at least one of red and blue sections to treat astigmatism.

10. The method of claim 1, wherein said spectral power distribution controlling step comprises filtering ambient light sources.

11. The method of claim 1, wherein said spectral power distribution controlling step comprises providing at least one ambient light source to provide a spectral power distribution of ambient visible light to treat the refractive abnormality.

12. The method of claim 11, wherein said refractive abnormality comprises myopia, and wherein said providing step comprises operating a blue ambient light source means which emits blue light to provide near work illumination.

13. The method of claim 4, further comprising the step of undercorrecting vision to bring an image formed by the visible light incident to the eye forward of the retina in the eye.

14. The method of claim 8, further comprising the step of undercorrecting vision to bring an image formed by the visible light incident to the eye behind the retina in the eye.

15. The method of claim 1, wherein said identifying step comprises the step of identifying myopia and astigmatism;

and wherein said spectral power distribution controlling step comprises the steps of;

filtering incident light to the eye to effect a change in the shape of the eye over time to treat the myopia; and

filtering further the incident light in a portion of the field of view of the eye to effect a change in the shape of the eye over time to treat the astigmatism.

16. The method of claim 1, wherein said identifying step comprises the step of identifying hyperopia and astigmatism;

and wherein said spectral power distribution controlling step comprises the steps of;

filtering incident light to the eye to effect a change in the shape of the eye over time to treat the hyperopia; and

filtering further the incident light to the eye in a portion of the field of view of the eye to effect a change in the shape of the eye over time to treat the astigmatism.

17. An apparatus for treating myopia in an eye comprising:

an optical device for passing light to the eye; and

a blue filter for filtering light passing through said optical device to the eye to effect a change in the shape of the eye over time to treat the myopia.

18. The apparatus of claim 17, wherein said optical device comprises at least one optical device selected from a group of eyeglasses, contact lenses, intra-ocular implants, and a magnifying lens.

19. The apparatus of claim 17, wherein said blue filter further comprises at least one of a blue tint and a blue optical filter.

20. The apparatus of claim 17, wherein said blue filter has a maximum transmittance percentage for light in a short wavelength range of the visible spectrum between 380 to 590 nm.

21. The apparatus of claim 17, wherein said blue filter has a maximum transmittance percentage for light in a short wavelength range of the visible spectrum between 430 to 530 nm.

22. The apparatus of claim 17, wherein said blue filter comprises light conversion means for converting the spectral power distribution of ambient artificial light to approximate the spectral power distribution of sunlight.

23. The apparatus of claim 17, wherein said blue filter comprises at least one light conversion filter having a Mired shift value approximately equal to -160 to treat myopia.

24. The apparatus of claim 23, wherein said at least one light conversion filter consists of two Wratten 80C filters.

25. A method for treating myopia in an eye, comprising the step of:

wearing the apparatus of claim 17 to effect a change in the shape of the eye over time to treat the myopia.

26. A light source apparatus for treating myopia, comprising:

a light source for emitting visible light; and

a blue filter for filtering the emitted light incident to an eye to effect a change in the shape of the eve over time to treat the myopia.

27. An apparatus for treating hyperopia comprising:

an optical device for passing light to an eye; and

a red filter for filtering light passing through said optical device to the eye to substantially block wavelengths less than 590 nm, and to effect a change in the shape of the eve over time to treat the hyperopia.

28. The apparatus of claim 27, wherein said optical device comprises at least one optical device selected from a group of eyeglasses, contact lenses, and intra-ocular implants.

29. The apparatus of claim 27, wherein said red filter further comprises at least one of a red tint and a red optical filter.

30. The apparatus of claim 27, wherein said red filter has a maximum transmittance percentage for light in a long wavelength range of the visible spectrum between 590 to 800 nm.

31. The apparatus of claim 27, wherein said red filter has a maximum transmittance percentage for light in a long wavelength range of the visible spectrum between 600 to 700 nm.

32. A method for treating hyperopia in an eye, comprising the step of:

wearing the apparatus of claim 27 to effect a change in the shape of the eye over time to treat the hyperopia.

33. A light source apparatus for treating hyperopia, comprising:

a light source for emitting visible light; and

a red filter for filtering the emitted light incident to an eye to substantially block wavelengths less than 590 nm, and to effect a change in the shape of the eye over time to treat the hyperopia.

34. An apparatus for treating astigmatism comprising:

an optical device for passing light to an eye; and

a sectioned-filter including red and blue filter sections for filtering light passing through said optical device to the eye to effect a change in the shape of the eve over time to treat the astigmatism.

35. The apparatus of claim 34, wherein said optical device comprises at least one optical device selected from a group of eyeglasses, contact lenses, and intraocular implants.

36. The apparatus of claim 34, wherein said sectioned-filter comprises at least one of a red filter section and a blue filter section, each red filter section includes at least one of a red tint and a red filter, and each blue filter section includes at least one of a blue tint and a blue filter.

37. A method for treating astigmatism in an eye, comprising the step of:

wearing the apparatus of claim 34 to effect a change in the shape of the eye over time to treat the astigmatism.

38. A method for treating myopia, comprising:

receiving incident visible light having a spectral distribution including red and blue spectral components at an eye; and

filtering said spectral distribution of the received incident light passing to the eye to reduce the magnitude of red spectral components relative to the magnitude of blue spectral components to treat the myopia such that a response of the eye to red spectral components which causes the eye to lengthen is prevented, mitigated, or reversed.

39. A method for treating hyperopia, comprising the steps of:

receiving incident visible light having a spectral distribution including red and blue spectral components; and

filtering said spectral distribution of the received incident light to reduce the magnitude of blue spectral components relative to the magnitude of red spectral components to treat the hyperopia such that a response of the eye to blue spectral components which causes the eye to shorten is prevented, mitigated, or reversed.

40. A method for treating astigmatism in an eye having at least first and second retina regions, wherein the astigmatism focuses light passing within the eye at a focus position behind the retina in the first retina region and in front of the retina in the second retina region, comprising the steps of:

receiving incident visible light having a spectral distribution including red and blue spectral components;

filtering a spectral distribution of the incident light in the field of view of the first retina region to reduce the magnitude of blue spectral components relative to the magnitude of red spectral components; and

filtering a spectral distribution of the incident light in the field of view of the second retina region to reduce the magnitude of red spectral components relative to the magnitude of blue spectral components such that a response of the eye at the first retina section to blue spectral components which causes the eye to shorten is prevented, mitigated, or reversed, and a response of the eye at the second retina section to red spectral components which causes the eye to lengthen is prevented, mitigated, or reversed.

41. A method for treating astigmatism, comprising the steps of:

receiving incident visible light having a spectral distribution including red and blue spectral components; and

filtering said spectral distribution of the received incident light to reduce the magnitude of red spectral components relative to the magnitude of blue spectral components to effect a change in the shape of the eye over time to treat the astigmatism in at least a portion of the field of view of an eye.

42. A method for treating astigmatism, comprising the steps of:

receiving incident visible light having a spectral distribution including red and blue spectral components; and

filtering said spectral distribution of the received incident light to reduce the magnitude of blue spectral components relative to the magnitude of red spectral components to effect a change in the shape of the eye over time to treat the astigmatism in at least a portion of the field of view of an eye.